Evidence map›Paper›PMID 24008353›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.

Kevin K Ogden, Alpa Khatri, Stephen F Traynelis, Scott A Heldt

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  4. Review
  5. Discovery of (Frontiers in chemistry · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Discovery of Dihydropyrrolo[1,2-Journal of medicinal chemistry · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Identification of AICP as a GluN2C-SelectiveMolecular pharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kevin K OgdenDepartment of Pharmacology, Emory University, Atlanta, GA, USA.
Alpa KhatriDepartment of Pharmacology, Emory University, Atlanta, GA, USA.
Stephen F TraynelisDepartment of Pharmacology, Emory University, Atlanta, GA, USA.
Scott A Heldt1] Department of Anatomy and Neurobiology [2] Neuroscience Institute, University of Tennessee Health Science Center, Memphis, TN, USA.
Emory University · USInstitute of Neurobiology · BG

Funding

Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Mechanism of Action of Novel Subunit-Selective NMDA Receptor ModulatorsR01NS065371 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2009 to 2018
$3.4M
The Role of Amygdala GABAergic Transmission in Fear and AnxietyR21MH086727 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI HELDT, SCOTT A · 2010 to 2011
$402k
NIGMS NIH HHS T32 GM008602NIMH NIH HHS MH-086727NINDS NIH HHS R01 NS065371
6 · The paper itself

Abstract

NMDA receptors are glutamate receptor ion channels that contribute to synaptic plasticity and are important for many forms of learning and memory. In the amygdala, NMDA receptors are critical for the acquisition, retention, and extinction of classically conditioned fear responses. Although the GluN2B subunit has been implicated in both the acquisition and extinction of conditioned fear, GluN2C-knockout mice show reduced conditioned fear responses. Moreover, D-cycloserine (DCS), which facilitates fear extinction, selectively enhances the activity of GluN2C-containing NMDA receptors. To further define the contribution of GluN2C receptors to fear learning, we infused the GluN2C/GluN2D-selective potentiator CIQ bilaterally into the basolateral amygdala (3, 10, or 30 μg/side) following either fear conditioning or fear extinction training. CIQ both increased the expression of conditioned fear 24 h later and enhanced the extinction of the previously conditioned fear response. These results support a critical role for GluN2C receptors in the amygdala in the consolidation of learned fear responses and suggest that increased activity of GluN2C receptors may underlie the therapeutic actions of DCS.

Indexed as

AmygdalaAnimalsArea Under CurveBenzimidazolesConditioning, PsychologicalDose-Response Relationship, DrugExtinction, PsychologicalFearGene Expression RegulationMaleMaze LearningMiceMice, Inbred C57BLMice, KnockoutMicroinjectionsMotor Activity2-amino-3-methylimidazo(1,2-d)naphthaleneBenzimidazolesNR2C NMDA receptorReceptors, N-Methyl-D-Aspartate

Identifiers

PMID24008353
PMCPMC3895240
OpenAlexW2018224009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.